Michael Potter
- Immunology top 0.2%
- T-cell and B-cell Immunology 24
- Complement system in diseases 15
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 65
-
- Monoclonal and Polyclonal Antibodies Research 74
- Molecular Biology top 0.5%
- Glycosylation and Glycoproteins Research 74
- Protein Degradation and Inhibitors 12
- Immunology and Allergy top 1%
-
- Drug Transport and Resistance Mechanisms 15
-
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Stuart RudikoffRose LiebermanThelma B. DunnRichard P. NordanJ S WaxJ. Frederic MushinskiEduardo A. PadlanHerman N. Eisen
- Journals
- Current topics in microbiology and immunology (42 papers)The Journal of Experimental Medicine (27 papers)Proceedings of the National Academy of Sciences (21 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael Potter
280 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Immunology 4.6k
- Hematology 2.2k
- Radiology, Nuclear Medicine and Imaging 4.0k
- Molecular Biology 6.8k
- Immunology and Allergy 542
Countries citing papers authored by Michael Potter
This map shows the geographic impact of Michael Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Potter more than expected).
Fields of papers citing papers by Michael Potter
This network shows the impact of papers produced by Michael Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Potter. The network helps show where Michael Potter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Potter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | Mineral resource of the month: vermiculite | 2008 | 1 |
| 3 | 2008 | 108 | |
| 4 | 2007 | 25 | |
| 5 | 2005 | 19 | |
| 6 | 2002 | 28 | |
| 7 | Adjuvant use of GM-CSF in invasive aspergillosis. | 1998 | 2 |
| 8 | 1996 | 9 | |
| 9 | A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. | 1992 | 31 |
| 10 | 1991 | 14 | |
| 11 | 1989 | 27 | |
| 12 | 1988 | 14 | |
| 13 | 1985 | 68 | |
| 14 | 1984 | 26 | |
| 15 | 1983 | 3 | |
| 16 | 1981 | 8 | |
| 17 | 1977 | 21 | |
| 18 | 1975 | 18 | |
| 19 | 1974 | 206 | |
| 20 | A resumé of the current status of the development of plasma-cell tumors in mice. | 1968 | 17 |
About Michael Potter
Michael Potter is a scholar working on Hematology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 284 papers that have together received 12.7k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (74 papers), Monoclonal and Polyclonal Antibodies Research (74 papers), Multiple Myeloma Research and Treatments (65 papers), T-cell and B-cell Immunology (24 papers), Complement system in diseases (15 papers), Drug Transport and Resistance Mechanisms (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Protein Degradation and Inhibitors (12 papers). The work is most often cited by research in Immunology (4.6k citations), Hematology (2.2k citations) and Radiology, Nuclear Medicine and Imaging (4.0k citations). Michael Potter has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stuart Rudikoff, Rose Lieberman, Thelma B. Dunn, Richard P. Nordan, J S Wax, J. Frederic Mushinski, Eduardo A. Padlan, Herman N. Eisen, Ernest S. Simms and Janet G. Pumphrey. Their work appears in journals such as Current topics in microbiology and immunology, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.